Multimodality MRI and Liquid Biopsy in GBM

Clinical trial NCT04776980 · WITHDRAWN

Trial details

NCT number: NCT04776980
Sponsor: Abramson Cancer Center at Penn Medicine
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Brain Tumor, Adult: Glioblastoma Brain Tumor, Recurrent Brain Tumor, Primary

Start date: 2022-06-01
Primary completion: 2022-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.